X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
star p-2 trial (52) 52
humans (42) 42
female (37) 37
index medicus (36) 36
tamoxifen (33) 33
raloxifene (30) 30
surgical adjuvant breast (27) 27
breast cancer (25) 25
oncology (25) 25
postmenopausal women (25) 25
breast neoplasms - prevention & control (22) 22
bowel project (16) 16
risk factors (15) 15
cancer (14) 14
prevention (14) 14
randomized-trial (13) 13
risk (13) 13
tamoxifen - therapeutic use (13) 13
breast neoplasms - drug therapy (12) 12
chemoprevention (11) 11
article (10) 10
estrogen (10) 10
middle aged (10) 10
selective estrogen receptor modulators - therapeutic use (10) 10
aged (9) 9
antineoplastic agents, hormonal - therapeutic use (9) 9
obstetrics & gynecology (9) 9
quality-of-life (9) 9
raloxifene hydrochloride - therapeutic use (9) 9
selective estrogen receptor modulators - pharmacology (9) 9
animals (8) 8
astronomy & astrophysics (8) 8
breast neoplasms - genetics (8) 8
breast-cancer (8) 8
care and treatment (7) 7
clinical trials as topic (7) 7
osteoporosis (7) 7
postmenopause (7) 7
randomized controlled-trial (7) 7
selective estrogen receptor modulator (7) 7
prevention trial (6) 6
quality of life (6) 6
research (6) 6
selective estrogen receptor modulators (6) 6
selective estrogen receptor modulators - adverse effects (6) 6
tamoxifen - adverse effects (6) 6
vertebral fracture risk (6) 6
adult (5) 5
aromatase inhibitors - therapeutic use (5) 5
brca2 mutation carriers (5) 5
chemotherapy, adjuvant (5) 5
estrogen receptor (5) 5
health aspects (5) 5
internal medicine (5) 5
nsabp (5) 5
obstetrics and gynecology (5) 5
pharmacology & pharmacy (5) 5
planetary systems (5) 5
raloxifene hydrochloride - adverse effects (5) 5
therapy (5) 5
women (5) 5
antineoplastic agents - therapeutic use (4) 4
aromatase inhibitors (4) 4
astrophysics (4) 4
astrophysics - earth and planetary astrophysics (4) 4
bone-mineral density (4) 4
breast neoplasms - epidemiology (4) 4
chemotherapy (4) 4
genetic aspects (4) 4
high-risk (4) 4
hormones, hormone substitutes, and hormone antagonists (4) 4
medicine & public health (4) 4
medicine, general & internal (4) 4
oncology, experimental (4) 4
orbits (4) 4
osteoporosis, postmenopausal - prevention & control (4) 4
outcomes (4) 4
ovarian cancer (4) 4
physics - earth and planetary astrophysics (4) 4
receptors, estrogen - metabolism (4) 4
risk assessment (4) 4
serm (4) 4
stars (4) 4
tamoxifen - pharmacology (4) 4
techniques: spectroscopic (4) 4
astrophysics - solar and stellar astrophysics (3) 3
astrophysics, cosmology and astronomy (3) 3
bazedoxifene/conjugated estrogens (3) 3
biochemistry & molecular biology (3) 3
biomarkers (3) 3
breast neoplasms - etiology (3) 3
breast neoplasms - metabolism (3) 3
breast neoplasms - pathology (3) 3
breast neoplasms - therapy (3) 3
continuing outcomes relevant (3) 3
coronary-heart-disease (3) 3
decision making (3) 3
decision-making (3) 3
double-blind method (3) 3
dwarf stars (3) 3
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


British Journal of Cancer, ISSN 0007-0920, 07/2013, Volume 109, Issue 1, pp. 1 - 7
Journal Article
Cancer Prevention Research, ISSN 1940-6207, 08/2017, Volume 10, Issue 8, pp. 431 - 433
Despite FDA approval of drugs to reduce the risk of breast cancer in women at increased risk, uptake of these drugs has been poor despite the publication of... 
BREAST-CANCER | ONCOLOGY | RALOXIFENE | TAMOXIFEN | RISK | OUTCOMES | NSABP | STAR P-2 TRIAL
Journal Article
BRITISH JOURNAL OF CANCER, ISSN 0007-0920, 05/2018, Volume 118, Issue 9, pp. 1 - 7
Prophylactic drug treatment with aspirin, statins and anti-hypertensive agents has had a major impact on the incidence of cardiovascular disease and is now... 
MAMMOGRAPHIC DENSITY | SURGICAL ADJUVANT BREAST | ONCOLOGY | TAMOXIFEN | RANDOMIZED-TRIAL | RISK | BOWEL PROJECT | STAR P-2 TRIAL | AROMATASE INHIBITORS | 20-YEAR FOLLOW-UP | COLORECTAL ADENOMAS | Aspirin | Risk groups | Toxicity | Vaccination | Aromatase | Viruses | Breast cancer | Tamoxifen | Cardiovascular diseases | Statins | Cancer | Esophagus | Review
Journal Article
Journal Article
Oncology Reports, ISSN 1021-335X, 09/2013, Volume 30, Issue 3, pp. 1019 - 1029
Journal Article
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 11/2007, Volume 25, Issue 32, pp. 5133 - 5140
To evaluate and improve the use of cancer trial end points that reflect the patient's own perspective, the National Cancer Institute organized an international... 
BREAST-CANCER | INSTITUTE | MANAGEMENT | ONCOLOGY | RALOXIFENE | TAMOXIFEN | QUALITY-OF-LIFE | OVARIAN-CANCER | INTRAPERITONEAL | STAR P-2 TRIAL | CHEMOTHERAPY | Decision Making | Neoplasms - therapy | Clinical Trials as Topic - trends | Sickness Impact Profile | Humans | Quality Indicators, Health Care | Quality of Life | Treatment Outcome | Patient Satisfaction
Journal Article
Breast Cancer Research and Treatment, ISSN 0167-6806, 7/2012, Volume 134, Issue 1, pp. 299 - 306
Journal Article